scholarly article | Q13442814 |
P50 | author | Benjamin Djulbegovic | Q28050789 |
Mark Fung | Q40348740 | ||
Brenda J. Grossman | Q43291752 | ||
P2093 | author name string | Aryeh Shander | |
Kelley E Capocelli | |||
Paul D Mintz | |||
Edward C Wong | |||
Claudia S Cohn | |||
Kathryn E Webert | |||
Richard M Kaufman | |||
Aaron A R Tobian | |||
Mark D Cipolle | |||
Steven Kleinman | |||
Alan T Tinmouth | |||
Babu G Welch | |||
Glenn J Whitman | |||
Robert Weinstein | |||
Deborah A Sesok-Pizzini | |||
Terry Gernsheimer | |||
AABB | |||
Barbara A O'Malley | |||
Gary E Stack | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | platelet transfusion | Q23925170 |
P304 | page(s) | 205-213 | |
P577 | publication date | 2015-02-01 | |
P1433 | published in | Annals of Internal Medicine | Q564416 |
P1476 | title | Platelet transfusion: a clinical practice guideline from the AABB. | |
P478 | volume | 162 |
Q50065194 | 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery |
Q38604021 | A FHIR Human Leukocyte Antigen (HLA) Interface for Platelet Transfusion Support |
Q49886715 | A Focused Review of Safety Considerations in Cancer Rehabilitation. |
Q28828539 | A Review of Radiation-Induced Coagulopathy and New Findings to Support Potential Prevention Strategies and Treatments |
Q38857160 | A Snapshot of Coagulopathy After Cardiopulmonary Bypass |
Q48217858 | A portable system for processing donated whole blood into high quality components without centrifugation |
Q89970279 | A systematic review and meta-analysis of traumatic intracranial hemorrhage in patients taking prehospital antiplatelet therapy: Is there a role for platelet transfusions? |
Q24186913 | A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation |
Q38770343 | AABB Committee Report: reducing transfusion-transmitted cytomegalovirus infections |
Q49543563 | Advances in transfusion medicine RCPath, November 2016. |
Q48272685 | Agonist-induced platelet reactivity correlates with bleeding in haemato-oncological patients |
Q33889604 | Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral Blood |
Q33440816 | Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort |
Q36282986 | Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates |
Q47792251 | Assessing thrombocytopenia in the intensive care unit: the past, present, and future |
Q50046039 | Assessment of Platelet Function in Traumatic Brain Injury-A Retrospective Observational Study in the Neuro-Critical Care Setting |
Q48157716 | Audit of appropriate use of platelet transfusions: validation of adjudication criteria |
Q39179984 | Bio-inspired nanomedicine strategies for artificial blood components |
Q47324534 | Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding. |
Q90706075 | Biometric Image Analysis for Quantitation of Dividing Platelets |
Q89465433 | Bleeding assessment and bleeding severity in thrombocytopenic patients undergoing invasive procedures |
Q52623903 | Bleeding frequency and characteristics among hematologic malignancy inpatient rehabilitation patients with severe thrombocytopenia. |
Q92136060 | Blood components requests at an orthopedic hospital: a critical survey |
Q30837280 | Blood product transfusion in emergency department patients: a case-control study of practice patterns and impact on outcome |
Q58731278 | Central Nervous System Bleeding After a Lumbar Puncture: Still an Ongoing Complication |
Q91643129 | Central venous catheterization in cancer patients with severe thrombocytopenia: Ultrasound-guide improves safety avoiding prophylactic platelet transfusion |
Q33421666 | Clinical practice of platelet transfusions in haemato-oncology |
Q57689300 | Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders |
Q37265484 | Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders. |
Q24187258 | Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia |
Q24187460 | Comparison of different platelet transfusion thresholds prior to insertion of central lines in patients with thrombocytopenia |
Q39201474 | Computerised decision support systems to promote appropriate use of blood products. |
Q38738078 | Continued decline in blood collection and transfusion in the United States-2015 |
Q49557978 | Current status of blood 'pharming': megakaryoctye transfusions as a source of platelets |
Q41839588 | Defining the effects of storage on platelet bioenergetics: The role of increased proton leak |
Q36205301 | Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials. |
Q52337406 | Developing a Comprehensive Perioperative Education Curriculum for Internal Medicine Residency Training. |
Q53838795 | Development of RBC transfusion indications and the collection of patient-specific pre-transfusion information. |
Q99563541 | Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH) |
Q38877308 | Development of autologous blood cell therapies |
Q38942854 | Development of the Platelet Efficacy Score (PEscore) to predict the efficacy of platelet transfusion in oncohematologic patients |
Q33422383 | Diagnosis and treatment of inherited thrombocytopenias. |
Q89804990 | Diagnosis of Inherited Platelet Disorders on a Blood Smear |
Q30315531 | Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thro |
Q52809462 | Differences in levels of platelet-derived microparticles in platelet components prepared using the platelet rich plasma, buffy coat, and apheresis procedures. |
Q39502184 | Effective implementation of a patient blood management programme for platelets. |
Q33435375 | Effectiveness of Pooled Platelet Transfusion in Concordant and Discordant Groups among Dengue Patients |
Q37512624 | Effectiveness of Provider Education Followed by Computerized Provider Order Entry Alerts in Reducing Inappropriate Red Blood Cell Transfusion. |
Q39366233 | Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjects |
Q50018924 | Efficacy of platelet transfusion for acute intracerebral hemorrhage among patients on antiplatelet therapy. |
Q91621150 | Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial |
Q35836174 | Embryonic stem cells as sources of donor-independent platelets |
Q90190150 | Emergency Reversal of Anticoagulation |
Q92744479 | Evaluation of platelet concentrate prescription in pediatric patients at a tertiary care hospital |
Q40095701 | Extracorporeal photopheresis practice patterns: An international survey by the ASFA ECP subcommittee |
Q90478614 | Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States |
Q38476069 | Gastrointestinal endoscopy in the cirrhotic patient |
Q33689210 | Goal-directed Hemostatic Resuscitation of Trauma-induced Coagulopathy: A Pragmatic Randomized Clinical Trial Comparing a Viscoelastic Assay to Conventional Coagulation Assays |
Q49989075 | Hereditary thrombocytopenias: a growing list of disorders |
Q91345020 | How clinicians can minimize transfusion-related adverse events? |
Q64232456 | How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa |
Q89972393 | Human megakaryocytic microparticles induce de novo platelet biogenesis in a wild-type murine model |
Q49330726 | Hyperleukocytosis in infant acute leukemia: a role for manual exchange transfusion for leukoreduction. |
Q38750017 | Image-guided intervention in the coagulopathic patient |
Q47805926 | Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation |
Q89943293 | Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro |
Q26775408 | Improving platelet transfusion safety: biomedical and technical considerations |
Q48298103 | In vitro properties of concentrated canine platelets stored in two additive solutions: a comparative study |
Q39320771 | Indications for and complications of transfusion and the management of gynecologic malignancies |
Q54941852 | Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field. |
Q38646788 | Investigation of the status quo of massive blood transfusion in China and a synopsis of the proposed guidelines for massive blood transfusion |
Q33437439 | In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice |
Q37566550 | Is platelet transfusion associated with hospital-acquired infections in critically ill patients? |
Q37417311 | Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party. |
Q64905531 | Longitudinal Study of Transfusion Utilization in Hospitalized Veterans. |
Q91979047 | Management of Thrombocytopenia in Cancer Patients |
Q33437777 | Management of severe dengue hemorrhagic fever and bleeding complications in a primigravida patient: a case report |
Q93075950 | Mortality After Traumatic Brain Injury in Elderly Patients: A New Scoring System |
Q38936224 | National and International Guidelines for Patient Blood Management in Obstetrics: A Qualitative Review |
Q90016772 | Neonatal and pediatric platelet transfusions: current concepts and controversies |
Q30248755 | Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials. |
Q55173128 | Optimizing donor scheduling before recruitment: An effective approach to increasing apheresis platelet collections. |
Q33428044 | Oral surgery in a patient with cirrhosis and thrombocytopenia: a case report |
Q37522553 | Organ transplantation and drug eluting stents: Perioperative challenges |
Q90449174 | Pathogen inactivation/reduction technologies for platelet transfusion: Where do we stand? |
Q38909287 | Peridischarge prophylactic platelet transfusions after stem cell transplant: is a tranfusion trigger needed? |
Q90373833 | Platelet Transfusion Practice and Related Outcomes in Pediatric Extracorporeal Membrane Oxygenation |
Q90217546 | Platelet Transfusion: And Update on Challenges and Outcomes |
Q64235625 | Platelet count abnormalities and peri-operative outcomes in adults undergoing elective, non-cardiac surgery |
Q38930441 | Platelet function testing in cardiac surgery |
Q104615341 | Platelet supernatant with longer storage inhibits tumor cell growth |
Q33420604 | Platelet transfusion and catheter insertion for plasma exchange in patients with thrombotic thrombocytopenic purpura and a low platelet count. |
Q33920013 | Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions |
Q39766998 | Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial |
Q90422944 | Platelet transfusion: Current challenges |
Q33427993 | Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unit |
Q47988283 | Port Implantation in Patients with Severe Thrombocytopenia is Safe with Interventional Radiology |
Q89857476 | Prediction of perioperative transfusions using an artificial neural network |
Q92260048 | Preoperative moderate thrombocytopenia is not associated with increased blood loss for low-risk cesarean section: a retrospective cohort study |
Q33426526 | Preoperative use of platelets in a 6-year-old with acute appendicitis and a myosin heavy chain 9-related disorder: a case report and review of literature |
Q50164120 | Prophylactic Platelet Transfusions for Critically Ill Patients With Thrombocytopenia: A Single-Institution Propensity-Matched Cohort Study |
Q49795614 | Prophylactic platelet transfusion prior to central venous catheter placement in patients with thrombocytopenia: study protocol for a randomised controlled trial |
Q49899043 | Prophylactic platelet transfusions prior to surgery for people with a low platelet count |
Q57156182 | Prophylactic platelet transfusions prior to surgery for people with a low platelet count |
Q37539104 | Quality Assessment of Established and Emerging Blood Components for Transfusion |
Q33436425 | Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study |
Q36515685 | Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. |
Q50227235 | Red blood cell transfusion: 2016 clinical practice guidelines from AABB. |
Q91471131 | Reflections on the dynamics of bacterial and viral contamination of blood components and the levels of efficacy for pathogen inactivation processes |
Q39627599 | Relative impact of a patient blood management program on utilization of all three major blood components |
Q91491530 | Released washed platelet concentrates are effective and safe in patients with a history of transfusion reactions |
Q103723156 | Retrospective evaluation of lumbar puncture and intrathecal chemotherapy in thrombocytopenic patients |
Q92616051 | Risk Factors for Transfusion after Orthotopic Liver Transplantation |
Q38719988 | Risk of Procedural Hemorrhage |
Q33428627 | Safety and Feasibility of Transradial Access for Visceral Interventions in Patients with Thrombocytopenia |
Q33429670 | Safety of lumbar punctures in patients with thrombocytopenia |
Q64987868 | Severe Intracranial Hemorrhage at Initial Presentation of Acute Myelogenous Leukemia. |
Q89839593 | Slowing decline in blood collection and transfusion in the United States - 2017 |
Q48248982 | Storage time of platelet concentrates and risk of a positive blood culture: a nationwide cohort study |
Q89960519 | Successful Introduction of Peritoneal Dialysis in an End-stage Renal Failure Patient with Idiopathic Aplastic Anemia |
Q38433744 | Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. |
Q64111058 | The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition |
Q39354273 | The effect of ambient exposure to PM2.5 on the transfusion usage of blood components and adverse transfusion reactions in the haze weather |
Q33439851 | The practice of platelet transfusion prior to central venous catheterization in presence of coagulopathy: a national survey among clinicians |
Q88030333 | The use of historical platelet counts from blood donors to program apheresis platelet donation: An Australian perspective |
Q33429614 | Therapy with blood products |
Q33442942 | Thrombocytopenia and Neurosurgery: A Literature Review. |
Q91178764 | Thrombocytopenia and Procedural Prophylaxis in the Era of Thrombopoietin Receptor Agonists |
Q55421841 | Thrombocytopenia and bleeding in myelosuppressed transfusion-dependent patients: a simulation study exploring underlying mechanisms. |
Q33430836 | Thrombocytopenia and craniotomy for tumor: A National Surgical Quality Improvement Program analysis |
Q24186714 | Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours |
Q47409875 | Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours |
Q33442786 | Towards the Manufacture of Megakaryocytes and Platelets for Clinical Application. |
Q48733691 | Transfusion in Traumatic Brain Injury |
Q59800395 | Transfusion-associated graft-versus-host disease: A concise review |
Q52683113 | Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014. |
Q99405711 | Unexpected arteriovenous malformation of the thyroid resulting in significant intraoperative blood loss |
Q24187543 | Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia |
Q26471928 | Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia |
Q57689341 | Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia |
Q47915048 | What is the evidence for platelet transfusion in perioperative settings? |
Q91924645 | Why some donors are more willing to donate platelets? ----a qualitative study on 25 regular platelet donors in Guangzhou, China |
Q33437019 | Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States |
Q33877117 | Wound healing: time to look for intelligent, 'natural' immunological approaches? |
Q90745531 | [Comparative study on platelet transfusion in Lorraine-Champagne and Alsace in 2015] |
Search more.